Emerging Therapeutic Targets in Ovarian Cancer

Stan Kaye, Robert Brown, Hani Gabra, Martin Gore (Herausgeber)

Buch | Softcover

291 Seiten

2014 | 2011 ed.
Springer-Verlag New York Inc.
978-1-4899-8233-9 (ISBN)

Artikel merken

This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.

1Existing treatment for ovarian cancer: recent advances and description of unmet needsS Banerjee M Bookman M Gore 2Discovery of novel targetsJ Farley M Birrer 3Anti-angiogenesis - update on its application in ovarian cancerJ Hasan G Jayson 4Targeting the PI3K/AKT pathwayE Stronach A Cheraghchi-Bashi M Chen H Gabra 5Inhibition of the SRC oncogene; potential in ovarian cancerLY Han AK Sood 6Tumour specific synthetic lethality; targeting BRCA gene dysfunctionTA Yap SB Kaye A Ashworth A Tutt 7Inhibition of cytokines and chemokines in ovarian cancerJ Coward F Balkwill 8Potential for inhibition of membrane receptors (EGF, IGF, c-MET, and others)LP Martin JJ Perkins R Schilder 9An epigenetic approach to ovarian cancerR Brown N Chapman-Rothe R Glasspool 10Immunotherapy; update on its application in ovarian cancerS Ghaem-Maghami M Gore 11Ovarian cancer progenitor/stem cells; therapeutic potentialS Murphy A Berchuck 12Potential for alpha-folate receptor targeted treatment for ovarian cancerCHM Ng A Jackman 13New insights into tubulin bindersJ Brenton

Erscheint lt. Verlag	27.11.2014
Zusatzinfo	XIII, 291 p.
Verlagsort	New York
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Studium
ISBN-10	1-4899-8233-7 / 1489982337
ISBN-13	978-1-4899-8233-9 / 9781489982339
Zustand	Neuware